ProfileGDS4718 / 227618_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 42% 34% 85% 31% 34% 31% 33% 29% 44% 37% 36% 39% 37% 31% 29% 42% 33% 39% 31% 44% 38% 37% 33% 40% 35% 35% 44% 25% 40% 31% 26% 49% 38% 36% 34% 33% 29% 40% 28% 77% 40% 31% 56% 31% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.1015242
GSM549102patient 115, normal, homogenized [OPG study]4.7262134
GSM549104patient 119, normal, homogenized [OPG study]8.5231585
GSM549108patient 138, normal, homogenized [OPG study]4.6247731
GSM549119patient 077, normal, homogenized [OPG study]4.7450834
GSM549133patient 032, cancer, homogenized [OPG study]4.5401631
GSM549139patient 042, cancer, homogenized [OPG study]4.6309733
GSM549099patient 107, normal, homogenized [OPG study]4.5204729
GSM549109patient 139, normal, homogenized [OPG study]5.2295944
GSM549110patient 046, normal, homogenized [OPG study]4.8601937
GSM549114patient 063, normal, homogenized [OPG study]4.7676336
GSM549122patient 082, normal, homogenized [OPG study]4.9717239
GSM549134patient 033, cancer, homogenized [OPG study]4.8481637
GSM549136patient 036, cancer, homogenized [OPG study]4.5087531
GSM549140patient 044, cancer, homogenized [OPG study]4.4390129
GSM549111patient 047, normal, homogenized [OPG study]5.0548442
GSM549113patient 057, normal, homogenized [OPG study]4.5966833
GSM549132patient 031, cancer, homogenized [OPG study]4.9180339
GSM549137patient 038, cancer, homogenized [OPG study]4.5731
GSM549142patient 047, cancer, homogenized [OPG study]5.3371244
GSM549100patient 110, normal, homogenized [OPG study]4.9392538
GSM549107patient 135, normal, homogenized [OPG study]4.7975637
GSM549115patient 068, normal, homogenized [OPG study]4.6121133
GSM549116patient 072, normal, homogenized [OPG study]4.9550840
GSM549120patient 078, normal, homogenized [OPG study]4.7741535
GSM549131patient 030, cancer, homogenized [OPG study]4.7201135
GSM549118patient 074, normal, homogenized [OPG study]5.2071444
GSM549129patient 027, cancer, homogenized [OPG study]4.3563625
GSM549123patient 088, normal, homogenized [OPG study]4.9727540
GSM549124patient 006, cancer, homogenized [OPG study]4.6427931
GSM549126patient 015, cancer, homogenized [OPG study]4.3616526
GSM549128patient 025, cancer, homogenized [OPG study]5.460149
GSM549103patient 117, normal, homogenized [OPG study]4.9541538
GSM549117patient 073, normal, homogenized [OPG study]4.7573736
GSM549138patient 041, cancer, homogenized [OPG study]4.692234
GSM549141patient 045, cancer, homogenized [OPG study]4.6195433
GSM549130patient 028, cancer, homogenized [OPG study]4.5285529
GSM549101patient 111, normal, homogenized [OPG study]5.0102840
GSM549105patient 128, normal, homogenized [OPG study]4.4915528
GSM549106patient 134, normal, homogenized [OPG study]7.6437477
GSM549112patient 048, normal, homogenized [OPG study]4.9770340
GSM549125patient 011, cancer, homogenized [OPG study]4.5809731
GSM549127patient 024, cancer, homogenized [OPG study]5.9229356
GSM549135patient 035, cancer, homogenized [OPG study]4.5248231